Covidien completes $250M Somanetics buy
- July 28, 2010
Covidien plc said Wednesday it completed its $250 million acquisition of Somanetics Corp. The deal was announced a little more than a month ago. Somanetics, which develops, manufactures and sells noninvasive ... Read More